INR 205.0
(0.15%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 5.06 Billion INR | -20.04% |
2022 | 3.56 Billion INR | 15.25% |
2021 | 3.09 Billion INR | -1.45% |
2020 | 3.14 Billion INR | -4.71% |
2019 | 3.29 Billion INR | 8.88% |
2018 | 3.02 Billion INR | 10.05% |
2017 | 2.75 Billion INR | 8.73% |
2016 | 2.52 Billion INR | 17.1% |
2015 | 2.15 Billion INR | -16.97% |
2014 | 2.6 Billion INR | 24.14% |
2013 | 2.09 Billion INR | 23.12% |
2012 | 1.7 Billion INR | 29.93% |
2011 | 1.3 Billion INR | 67.84% |
2010 | 780.5 Million INR | 2.38% |
2009 | 762.38 Million INR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 730.72 Million INR | 0.9% |
2023 Q1 | 997.37 Million INR | 34.61% |
2023 Q4 | 724.17 Million INR | -21.98% |
2023 Q2 | 921.12 Million INR | -7.65% |
2023 Q3 | 928.19 Million INR | 0.77% |
2023 FY | 2.85 Billion INR | -20.04% |
2022 FY | 3.56 Billion INR | 15.25% |
2022 Q1 | 1.01 Billion INR | 49.25% |
2022 Q2 | 908.42 Million INR | -10.12% |
2022 Q3 | 906.16 Million INR | -0.25% |
2022 Q4 | 740.93 Million INR | -18.23% |
2021 Q1 | 746.96 Million INR | 15.32% |
2021 FY | 3.09 Billion INR | -1.45% |
2021 Q4 | 677.16 Million INR | -22.64% |
2021 Q3 | 875.32 Million INR | 10.11% |
2021 Q2 | 794.96 Million INR | 6.43% |
2020 Q1 | 677.91 Million INR | -4.75% |
2020 Q3 | 946.12 Million INR | 8.96% |
2020 FY | 3.14 Billion INR | -4.71% |
2020 Q2 | 868.31 Million INR | 28.09% |
2020 Q4 | 647.74 Million INR | -31.54% |
2019 FY | 3.29 Billion INR | 8.88% |
2019 Q1 | 884 Million INR | 34.75% |
2019 Q3 | 873.08 Million INR | 5.64% |
2019 Q2 | 826.44 Million INR | -6.51% |
2019 Q4 | 711.75 Million INR | -18.48% |
2018 FY | 3.02 Billion INR | 10.05% |
2018 Q4 | 656.05 Million INR | -18.54% |
2018 Q3 | 805.4 Million INR | 0.31% |
2018 Q2 | 802.89 Million INR | 5.34% |
2018 Q1 | 762.16 Million INR | 0.0% |
2017 FY | 2.75 Billion INR | 8.73% |
2016 FY | 2.52 Billion INR | 17.1% |
2015 FY | 2.15 Billion INR | -16.97% |
2014 FY | 2.6 Billion INR | 24.14% |
2013 FY | 2.09 Billion INR | 23.12% |
2013 Q3 | - INR | 0.0% |
2012 FY | 1.7 Billion INR | 29.93% |
2012 Q3 | - INR | 0.0% |
2011 FY | 1.3 Billion INR | 67.84% |
2010 FY | 780.5 Million INR | 2.38% |
2009 FY | 762.38 Million INR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Ador Multiproducts Limited | -2.72 Million INR | 186165.588% |
Ambica Agarbathies Aroma & Industries Limited | 277.34 Million INR | -1726.636% |
Colgate-Palmolive (India) Limited | 16.44 Billion INR | 69.201% |
Cupid Limited | 176 Million INR | -2778.488% |
Dabur India Limited | 21.91 Billion INR | 76.88% |
Emami Limited | 10.72 Billion INR | 52.758% |
Gillette India Limited | 5.5 Billion INR | 7.937% |
Godrej Consumer Products Limited | 73.4 Billion INR | 93.099% |
Hindustan Unilever Limited | 96.12 Billion INR | 94.729% |
Hipolin Limited | 51.32 Million INR | -9769.933% |
Honasa Consumer Limited | 8.36 Billion INR | 39.454% |
JHS Svendgaard Laboratories Limited | 183.68 Million INR | -2658.058% |
Jyothy Labs Limited | 5.16 Billion INR | 1.979% |
Kaya Limited | 852.48 Million INR | -494.277% |
Marico Limited | 21.36 Billion INR | 76.282% |
N.K Industries Limited | 201.82 Million INR | -2410.114% |
PAOS INDUSTRIES LIMITED | 513 Thousand INR | -987451.267% |
Paramount Cosmetics (India) Limited | 35.83 Million INR | -14036.219% |
Pee Cee Cosma Sope Limited | 427.25 Million INR | -1085.752% |
Procter & Gamble Hygiene and Health Care Limited | 8.13 Billion INR | 37.733% |